Zika Virus Therapeutics Market Size to Grow by USD 4.97 Bn, 37% of Market Growth to Originate from North America - Technavio

NEW YORK, Oct. 31, 2022 /PRNewswire/ -- The Zika virus therapeutics market size is estimated to grow by USD 4.97 billion from 2021 to2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.25% during the forecast period, according to Technavio. The market has been segmented by product (acetaminophen and other NSAIDs) and geography (North America, Europe, Asia, and Rest of World (ROW)).

View a comprehensive report summary that describes the market size and forecast along with the research methodology. Download a FREE PDF Sample Report

By geography, North America will account for 37% of the market's growth during the forecast period. This growth is attributed to factors such as the increasing incidence of Zika virus infection in countries such as the US. Moreover, market growth in this region will be faster than the growth of the market in Rest of World (ROW). The US and Canada are the key countries for the Zika virus therapeutics market in North America.

Get lifetime access to our Technavio Insights! Subscribe to our Basic Plan billed annually at USD 5000

By product, the acetaminophen segment will be a significant contributor to market growth during the forecast period. Acetaminophen, which is also known as TYLENOL, is the most widely used analgesic and the first-line therapy for the treatment of pain conditions. Acetaminophen has an antipyretic effect and also helps in reducing fever. Hence, acetaminophen is used to provide symptomatic relief for patients with Zika virus infections.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. Download FREE PDF Sample Report

The availability of serology kits for qualitative diagnosis of Zika virus infection is driving the market. Recently, a serology kit named ZIKV Detect 2.0 IgM Capture ELISA by InBios International Inc. was approved for the qualitative diagnosis of Zika virus immunoglobulin M (IgM) antibodies in the human serum. It is widely used for Zika diagnostic tests in the US and is designed to identify the presence of IgM antibodies that are produced by the body's natural immune system upon exposure to the Zika virus. These factors will boost the demand for Zika virus therapeutics during the forecast period.

Increasing efforts by government and private organizations to facilitate vaccine development is a key trend in the market. Various other government and non-government bodies, along with the WHO and the UNICEF, are taking initiatives to develop a vaccine against the Zika virus. For instance, the NIAID is conducting a Phase I trial for ZPIV, which is being tested in adults in a Flavivirus endemic area. The NIAID and the WRAIR are together conducting a Phase I trial for ZPIV accelerated vaccination schedule study. On May 4, 2022, Moderna announced its confirmation of an ongoing Phase II clinical trial of its mRNA-1893 candidate in Puerto Rico the US.

Identify key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors in this report. Buy Now for detailed vendor information

Cytomegalovirus (CMV) Therapeutics Market by Route of Administration and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by route of administration (oral, parenteral, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). 37% of the market's growth will originate from North America during the forecast period. The market share growth by the oral segment will be significant.

Human Papillomavirus (HPV) Therapeutics Market by Route of Administration and Geography - Forecast and Analysis 2022-2026: This report extensively covers segmentation by route of administration (parenteral and topical) and geography (North America, Europe, Asia, and Rest of World (ROW)). 50% of the market's growth will originate from North America during the forecast period. The market share growth by the parenteral segment will be significant.

Browse Health Care Market Reports

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

• 5.1 Market segments 
• Exhibit 24: Chart on Product - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

• 5.2 Comparison by Product 
• Exhibit 26: Chart on Comparison by Product
• Exhibit 27: Data Table on Comparison by Product

• 5.3 Acetaminophen - Market size and forecast 2021-2026
• Exhibit 28: Chart on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Acetaminophen - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Acetaminophen - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Acetaminophen - Year-over-year growth 2021-2026 (%)

• 5.4 Other NSAIDs - Market size and forecast 2021-2026
• Exhibit 32: Chart on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Other NSAIDs - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Other NSAIDs - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Other NSAIDs - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Product 
• Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 38: Chart on Market share by geography 2021-2026 (%)
• Exhibit 39: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 40: Chart on Geographic comparison
• Exhibit 41: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Denmark - Market size and forecast 2021-2026
• Exhibit 62: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Denmark - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026
• Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.11 India - Market size and forecast 2021-2026
• Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 78: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 79: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 80: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 81: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 82: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 83: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 84: Matrix on vendor position and classification

• 10.3 Aurobindo Pharma Ltd. 
• Exhibit 85: Aurobindo Pharma Ltd. - Overview
• Exhibit 86: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 87: Aurobindo Pharma Ltd. - Key offerings

• 10.4 Bharat Biotech Ltd. 
• Exhibit 88: Bharat Biotech Ltd. - Overview
• Exhibit 89: Bharat Biotech Ltd. - Product / Service
• Exhibit 90: Bharat Biotech Ltd. - Key news
• Exhibit 91: Bharat Biotech Ltd. - Key offerings

• 10.5 Emergent BioSolutions Inc. 
• Exhibit 92: Emergent BioSolutions Inc. - Overview
• Exhibit 93: Emergent BioSolutions Inc. - Product / Service
• Exhibit 94: Emergent BioSolutions Inc. - Key news
• Exhibit 95: Emergent BioSolutions Inc. - Key offerings

• 10.6 GeoVax Labs Inc. 
• Exhibit 96: GeoVax Labs Inc. - Overview
• Exhibit 97: GeoVax Labs Inc. - Product / Service
• Exhibit 98: GeoVax Labs Inc. - Key news
• Exhibit 99: GeoVax Labs Inc. - Key offerings

• 10.7 Granules India Ltd. 
• Exhibit 100: Granules India Ltd. - Overview
• Exhibit 101: Granules India Ltd. - Product / Service
• Exhibit 102: Granules India Ltd. - Key news
• Exhibit 103: Granules India Ltd. - Key offerings

• 10.8 IMV Inc. 
• Exhibit 104: IMV Inc. - Overview
• Exhibit 105: IMV Inc. - Product / Service
• Exhibit 106: IMV Inc. - Key news
• Exhibit 107: IMV Inc. - Key offerings

• 10.9 Johnson and Johnson 
• Exhibit 108: Johnson and Johnson - Overview
• Exhibit 109: Johnson and Johnson - Business segments
• Exhibit 110: Johnson and Johnson - Key news
• Exhibit 111: Johnson and Johnson - Key offerings
• Exhibit 112: Johnson and Johnson - Segment focus

• 10.10 Perrigo Co. Plc 
• Exhibit 113: Perrigo Co. Plc - Overview
• Exhibit 114: Perrigo Co. Plc - Business segments
• Exhibit 115: Perrigo Co. Plc - Key offerings
• Exhibit 116: Perrigo Co. Plc - Segment focus

• 10.11 Sun Pharmaceutical Industries Ltd. 
• Exhibit 117: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 118: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 119: Sun Pharmaceutical Industries Ltd. - Key offerings

• 10.12 Takeda Pharmaceutical Co. Ltd. 
• Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations 
• Exhibit 130: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio